MSInsight in the spolight of BigBooster
🌍 We’re thrilled to announce that MSInsight has been selected among the startups of season 7 of the prestigious international acceleration program, BigBooster. This […]
Catégorie : Technology
Meet our team at the national congress on tumor with microsatellite instability
📢 MSInsight will be present at the very first national inter-SiRIC congress dedicated to microsatellite instability (MSI) cancers. Join us to exchange […]
Alex Duval, CSO of MSInsight, laureat of Raymond Rosen Prize from the Fondation pour la Recherche Médicale
🏅 Great News! Our CSO and co-founder, Alex Duval, has been awarded the 2023 Raymond Rosen Prize by the Fondation pour […]
SFMPP Axel Khan Award to our CTO, Toky Ratovomanana, for his work on prediction to response to immunotherapy for MSI metastatic colorectal cancer
🏆 Our partner from CRSA PARIS and our CTO Toky Ratovomanana have been honored with the prestigious Axel Kahn Award by the SFMPP – Société […]
New publication on prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
👏 Thrilled to share a tremendous achievement with our contribution to an article accepted in Annals of Oncology🔍 This publication emphasizes […]
MSInsight integrates Paris Saclay Cancer Cluster
🚀 MSInsight has been selected to be part of Paris Saclay Cancer Cluster🗼.🔬 The PSCC gives innovators access to the best experts […]
La société MSInsight, lauréate du 25ème concours d’innovation i-Lab
Startup spécialisée en génomique et bioinformatique en faveur de la lutte contre le cancer, MSInsight a été sélectionnée comme lauréate […]
Aliquam erat volutpat phasellus eget
Aenean eleifend odio vitae leo ultricies feugiat. Nam ut enim a augue viverra volutpat vel et mi. In ultrices lacinia […]
